EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY 4.0

Development and proof-of-concept evaluation for a low resource compatible Chikungunya virus diagnostic

Rickyle Balea iD, Alberto A Amarilla, Jody Hobson-Peters, Joanne Macdonald, Andreas Suhrbier, Vasilli M Kasimov, Daniel Watterson, Nina M Pollak, David J McMillan

PLOS Neglected Tropical Diseases · 2025

DOI: 10.1371/journal.pntd.0012352 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von Rickyle Balea und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Science, Technology and Engineering, University of the Sunshine Coast, Sippy Downs, Queensland, Australia. Hauptthemen laut MEDLINE: Chikungunya virus, Chikungunya Fever, Molecular Diagnostic Techniques. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Training Program (RTP) Commonwealth Research Scholarship, Higher Education Support act 2003 with the University of the Sunshine Coast (QLD, Australia), Bill & Melinda Gates foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chikungunya virus (CHIKV) is a positive sense RNA Alphavirus that continues to pose major public health threats throughout the world. CHIKV is primarily transmitted via the Aedes genus mosquito; however, has also exhibited transmission routes via blood transfusion and vertical transmission (mother to child). With only one approved vaccine thus far and no approved medicines or specific therapeutics, early detection is crucial in mitigating potential CHIKV outbreaks. Here, we designed and evaluated a sensitive and specific CHIKV diagnostic using reverse transcription-recombinase aided amplification (RT-RAA) coupled lateral flow strip detection (LFD) targeting a highly conserved region of the CHIKV E1 gene. Our results demonstrate that using our simple sample preparation reagent (TNA-Cifer-E), we can inactivate live CHIKV in two minutes at room temperature, whilst also sustaining viable viral RNA. Our specificity analysis demonstrates the Iso-CHIKV-Dx does not detect any closely related Alphaviruses nor any of the common co-circulating Flaviviruses . Proof-of-concept evaluation using urine spiked with CHIKV exhibited that in CHIKV infected urine samples, our Iso-CHIKV-Dx can detect as low as 570 copies/µL of CHIKV RNA in 30 minutes under isothermal conditions. Contrary to conventional RT-qPCR, our Iso-CHIKV-Dx does not require expensive machinery, advanced instrumentation or extensively trained personnel. Further performance comparisons also show that our Iso-CHIKV-Dx is four times faster than conventional RNA isolation and RT-qPCR. As such, pre-clinical, proof-of-concept evaluation demonstrates that our Iso-CHIKV-Dx has the potential to act as a robust, point of care CHIKV diagnostic that could prove to be highly beneficial in place of, or in the absence of conventional diagnostic approaches such as RT-qPCR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chikungunya virusChikungunya FeverMolecular Diagnostic TechniquesHumansRNA, ViralSensitivity and SpecificityProof of Concept StudyNucleic Acid Amplification TechniquesAnimals

Substanzen

RNA, Viral

Autor:innen und Institutionen

  • School of Science, Technology and Engineering, University of the Sunshine Coast, Sippy Downs, Queensland, Australia.
  • School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, Queensland, Australia.
  • Centre for Bioinnovation, University of the Sunshine Coast, Sippy Downs, Queensland, Australia.
  • BioCifer Pty Ltd, Buderim, Queensland, Australia.
  • QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Institute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.

ORCID-Profile: Rickyle Balea

Förderung

  • Research Training Program (RTP) Commonwealth Research Scholarship
  • Higher Education Support act 2003 with the University of the Sunshine Coast (QLD, Australia)
  • Bill & Melinda Gates foundation
  • University of the Sunshine Coast
  • Bill and Melinda Gates Foundation

Zitieren

APA

Balea, R., Amarilla, A. A., Hobson-Peters, J., Macdonald, J., Suhrbier, A., Kasimov, V. M., Watterson, D., Pollak, N. M., & McMillan, D. J. (2025). Development and proof-of-concept evaluation for a low resource compatible Chikungunya virus diagnostic. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012352

Vancouver

Balea R, Amarilla AA, Hobson-Peters J, Macdonald J, Suhrbier A, Kasimov VM, et al. Development and proof-of-concept evaluation for a low resource compatible Chikungunya virus diagnostic. PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0012352

BibTeX
@article{Balea2025,
  author = {Balea, Rickyle and Amarilla, Alberto A and Hobson-Peters, Jody and Macdonald, Joanne and Suhrbier, Andreas and Kasimov, Vasilli M and Watterson, Daniel and Pollak, Nina M and McMillan, David J},
  title = {Development and proof-of-concept evaluation for a low resource compatible Chikungunya virus diagnostic},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2025},
  doi = {10.1371/journal.pntd.0012352}
}
Kostenlos starten →